Acute depression, stress, anxiety higher during peak of COVID-19 pandemic

24-Jul-2020 10:55 AM EDT, by PLOS

Newswise — Rates of elevated psychological distress, including depression and anxiety symptoms, were found among Australian adults during the peak of the COVID-19 outbreak in Australia, according to a new study published July 28, 2020 in the open-access journal PLOS ONE by Jill Newby of the University of New South Wales at the Black Dog Institute, Sydney, Australia, and colleagues. 

The acute and long-term mental health impacts of the COVID-19 pandemic are largely unknown. Research into previous pandemics has shown higher rates of illness fears, psychological distress, insomnia and other mental health problems in people with pre-existing mental illness, front-line health care workers, and survivors of the disease. Research into the mental health impacts of COVID-19 is needed to inform policy decisions, prevention efforts, treatment programs, and community support systems. 

In the new study, researchers used an online survey, administered March 27 through April 7—now considered to be the peak of the COVID-19 outbreak in Australia—to examine mental health responses to the pandemic among 5070 Australian adults. The online questionnaire asked participants about their fears, behavioral responses to COVID-19, psychological distress, alcohol use, and physical activity. A similar survey had already been carried out among 2,174 Australians in early March, when cases in the country were still low. 

The population included in the survey was not representative of the overall population; 70% had pre-existing mental health diagnoses, 86% were female, and 75% were Caucasian.  Although few participants had contracted COVID-1019 (0.15%), more than one-quarter (25.9%) were very or extremely worried about contracting the virus and more than half (52.7%) were very or extremely worried about their family and friends. While the questionnaires could not be used to make any diagnoses, most participants reported that their mental health had worsened during the outbreak, with 55% saying it had worsened a little and 23% saying it had worsened a lot. Around half of all participants reported moderate to extreme loneliness and worry about their financial situation. Between 20.3 and 24.1% of people surveyed had been experiencing severe or extremely severe levels of depression, anxiety and stress over the week preceding their survey, and another 18 to 22% had moderate symptoms. 

Newby says: “We wanted to provide a snapshot of the mental health of the general community during the COVID-19 outbreak and look into the impact of the enforcement of social distancing laws, in Australia.” She adds, “We don’t know what the long-term impacts of the pandemic will be, but these figures certainly show a negative impact on mental health in the short-term.”

 

Citation: Newby JM, O’Moore K, Tang S, Christensen H, Faasse K (2020) Acute mental health responses during the COVID-19 pandemic in Australia. PLoS ONE 15(7): e0236562. https://doi.org/10.1371/journal.pone.0236562 

Funding: This study was funded by a MRFF Career Development Fellowship to JMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 

Competing Interests: The authors have declared that no competing interests exist.

 

About PLOS ONE

PLOS ONE is a multidisciplinary, peer-reviewed open access journal that publishes sound science from all fields of scientific research.  For more information, visit http://journals.plos.org/plosone, and follow @PLOSONE on Twitter.

 

Media and Copyright Information

For information about PLOS ONE relevant to journalists, bloggers and press officers, including details of our press release process and embargo policy, visit http://journals.plos.org/plosone/s/press-and-media

PLOS Journals publish under a Creative Commons Attribution License, which permits free reuse of all materials published with the article, so long as the work is cited. 

 

About the Public Library of Science
Public Library of Science (PLOS) is a nonprofit Open Access publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by leading a transformation in research communication. The PLOS suite of journals contain rigorously peer-reviewed Open Access research articles from all areas of science and medicine, together with expert commentary and analysis. In addition to journals, the organization advances innovations in scientific publishing through Collections, Communities and The PLOS Blog Network. Founded to catalyze a revolution in scientific publishing by demonstrating the value and feasibility of Open Access publication, PLOS is committed to innovative and forward-looking solutions to scientific communication. For more information, visit http://www.plos.org.
 

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
1.18783